PubMed:18809620 / 1087-1261 JSONTXT

{"project":"CL-cell","denotations":[{"id":"T7","span":{"begin":163,"end":173},"obj":"Cell"}],"attributes":[{"id":"A7","pred":"cl_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CL:0000738"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":174},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":174},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T35","span":{"begin":11,"end":17},"obj":"FMAID:178661"},{"id":"_T36","span":{"begin":37,"end":41},"obj":"FMAID:214734"},{"id":"_T37","span":{"begin":152,"end":173},"obj":"FMAID:263007"},{"id":"_T38","span":{"begin":152,"end":173},"obj":"FMAID:263006"},{"id":"_T39","span":{"begin":163,"end":173},"obj":"FMAID:62852"},{"id":"_T40","span":{"begin":163,"end":173},"obj":"FMAID:167148"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GO-BP","denotations":[{"id":"T4","span":{"begin":72,"end":80},"obj":"http://purl.obolibrary.org/obo/GO_0009056"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T173","span":{"begin":0,"end":2},"obj":"PRP"},{"id":"EnjuParser_T174","span":{"begin":3,"end":10},"obj":"RB"},{"id":"EnjuParser_T175","span":{"begin":11,"end":17},"obj":"VBD"},{"id":"EnjuParser_T176","span":{"begin":18,"end":25},"obj":"IN"},{"id":"EnjuParser_T177","span":{"begin":26,"end":29},"obj":"DT"},{"id":"EnjuParser_T178","span":{"begin":30,"end":36},"obj":"NN"},{"id":"EnjuParser_T179","span":{"begin":37,"end":41},"obj":"JJ"},{"id":"EnjuParser_T180","span":{"begin":42,"end":50},"obj":"NN"},{"id":"EnjuParser_T181","span":{"begin":51,"end":53},"obj":"CC"},{"id":"EnjuParser_T182","span":{"begin":54,"end":57},"obj":"DT"},{"id":"EnjuParser_T183","span":{"begin":58,"end":71},"obj":"RB"},{"id":"EnjuParser_T184","span":{"begin":72,"end":80},"obj":"VBN"},{"id":"EnjuParser_T185","span":{"begin":81,"end":89},"obj":"NNS"},{"id":"EnjuParser_T186","span":{"begin":90,"end":95},"obj":"MD"},{"id":"EnjuParser_T187","span":{"begin":96,"end":102},"obj":"VB"},{"id":"EnjuParser_T188","span":{"begin":103,"end":119},"obj":"JJ"},{"id":"EnjuParser_T189","span":{"begin":120,"end":128},"obj":"NN"},{"id":"EnjuParser_T190","span":{"begin":129,"end":136},"obj":"IN"},{"id":"EnjuParser_T191","span":{"begin":137,"end":148},"obj":"NN"},{"id":"EnjuParser_T192","span":{"begin":149,"end":151},"obj":"IN"},{"id":"EnjuParser_T193","span":{"begin":152,"end":159},"obj":"NNS"},{"id":"EnjuParser_T194","span":{"begin":160,"end":162},"obj":"IN"},{"id":"EnjuParser_T195","span":{"begin":163,"end":173},"obj":"NNS"}],"relations":[{"id":"EnjuParser_R174","pred":"arg1Of","subj":"EnjuParser_T175","obj":"EnjuParser_T174"},{"id":"EnjuParser_R175","pred":"arg1Of","subj":"EnjuParser_T173","obj":"EnjuParser_T175"},{"id":"EnjuParser_R176","pred":"arg2Of","subj":"EnjuParser_T187","obj":"EnjuParser_T175"},{"id":"EnjuParser_R177","pred":"arg1Of","subj":"EnjuParser_T187","obj":"EnjuParser_T176"},{"id":"EnjuParser_R178","pred":"arg1Of","subj":"EnjuParser_T180","obj":"EnjuParser_T177"},{"id":"EnjuParser_R179","pred":"arg1Of","subj":"EnjuParser_T180","obj":"EnjuParser_T178"},{"id":"EnjuParser_R180","pred":"arg1Of","subj":"EnjuParser_T180","obj":"EnjuParser_T179"},{"id":"EnjuParser_R181","pred":"arg1Of","subj":"EnjuParser_T180","obj":"EnjuParser_T181"},{"id":"EnjuParser_R182","pred":"arg2Of","subj":"EnjuParser_T185","obj":"EnjuParser_T181"},{"id":"EnjuParser_R183","pred":"arg1Of","subj":"EnjuParser_T185","obj":"EnjuParser_T182"},{"id":"EnjuParser_R184","pred":"arg1Of","subj":"EnjuParser_T185","obj":"EnjuParser_T183"},{"id":"EnjuParser_R185","pred":"arg2Of","subj":"EnjuParser_T185","obj":"EnjuParser_T184"},{"id":"EnjuParser_R186","pred":"arg1Of","subj":"EnjuParser_T181","obj":"EnjuParser_T186"},{"id":"EnjuParser_R187","pred":"arg2Of","subj":"EnjuParser_T187","obj":"EnjuParser_T186"},{"id":"EnjuParser_R188","pred":"arg1Of","subj":"EnjuParser_T181","obj":"EnjuParser_T187"},{"id":"EnjuParser_R189","pred":"arg2Of","subj":"EnjuParser_T189","obj":"EnjuParser_T187"},{"id":"EnjuParser_R190","pred":"arg1Of","subj":"EnjuParser_T189","obj":"EnjuParser_T188"},{"id":"EnjuParser_R191","pred":"arg1Of","subj":"EnjuParser_T187","obj":"EnjuParser_T190"},{"id":"EnjuParser_R192","pred":"arg2Of","subj":"EnjuParser_T191","obj":"EnjuParser_T190"},{"id":"EnjuParser_R193","pred":"arg1Of","subj":"EnjuParser_T191","obj":"EnjuParser_T192"},{"id":"EnjuParser_R194","pred":"arg2Of","subj":"EnjuParser_T193","obj":"EnjuParser_T192"},{"id":"EnjuParser_R195","pred":"arg1Of","subj":"EnjuParser_T193","obj":"EnjuParser_T194"},{"id":"EnjuParser_R196","pred":"arg2Of","subj":"EnjuParser_T195","obj":"EnjuParser_T194"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GlyCosmos600-FMA","denotations":[{"id":"T10","span":{"begin":163,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma62852"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GlyCosmos15-CL","denotations":[{"id":"T7","span":{"begin":163,"end":173},"obj":"Cell"}],"attributes":[{"id":"A7","pred":"cl_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CL:0000738"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T7","span":{"begin":163,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CL_0000738"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T7","span":{"begin":0,"end":174},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":174},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":174},"obj":"Sentence"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T7","span":{"begin":163,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CL_0000738"}],"text":"We further tested whether the BP1002 main fraction or the enzymatically degraded products could induce immunomodulating activity through stimulation of subsets of leukocytes."}